JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeLander, G. E.
Right arrow Articles by Wahl, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeLander, G. E.
Right arrow Articles by Wahl, J. J.

Behavior induced by putative nociceptive neurotransmitters is inhibited by adenosine or adenosine analogs coadministered intrathecally

GE DeLander and JJ Wahl

College of Pharmacy, Oregon State University, Corvallis.

Adenosine agonists administered systemically, intracerebroventricularly and intrathecally have been demonstrated to induce antinociception. Results from studies utilizing intrathecal administration of adenosine or adenosine analogs, in particular, suggest that endogenous adenosine may inhibit the transmission of nociceptive impulses at spinal sites. The present investigations were performed to extend our understanding of the role of adenosine in antinociception by examining the effect of adenosine agonists on behavior induced by two putative spinal nociceptive neurotransmitters, substance P and N-methyl-D-aspartate. Coadministration of each of several adenosine agonists with substance P or N-methyl-D-aspartate intrathecally significantly decreased the intensity of behaviors induced by putative nociceptive neurotransmitters in mice. Adenosine agonist-mediated inhibition was antagonized by theophylline supporting adenosine agonist interactions with cell membrane surface adenosine receptors. Rank order potencies were determined for several adenosine analogs with varying selectivity for A1 and A2 adenosine receptor subtypes. However, rank order potencies did not correlate well with rank order potencies reported previously for adenosine receptor subtypes in biochemical assays. The results of these investigations demonstrate that adenosine inhibits behavior induced by nociceptive neurotransmitters interacting with spinal substance P or N-methyl-D-aspartate receptors. Furthermore, observations provide additional support for endogenous antinociceptive pathways that utilize adenosine at spinal sites.

Volume 246, Issue 2, pp. 565-570, 08/01/1988
Copyright © 1988 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
M. H. Yoon, H. B. Bae, and J. I. Choi
Antinociception of Intrathecal Adenosine Receptor Subtype Agonists in Rat Formalin Test
Anesth. Analg., November 1, 2005; 101(5): 1417 - 1421.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
G. Kekesi, I. Dobos, G. Benedek, and G. Horvath
The Antinociceptive Potencies and Interactions of Endogenous Ligands During Continuous Intrathecal Administration: Adenosine, Agmatine, and Endomorphin-1
Anesth. Analg., February 1, 2004; 98(2): 420 - 426.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
X. Li and J. D. Clark
Hyperalgesia During Opioid Abstinence: Mediation by Glutamate and Substance P
Anesth. Analg., October 1, 2002; 95(4): 979 - 984.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1988 by the American Society for Pharmacology and Experimental Therapeutics.